| Literature DB >> 24626206 |
S Jimenez-Jorge1, F Pozo, S de Mateo, C Delgado-Sanz, I Casas, M Garcia-Cenoz, J Castilla, R Sancho, L Etxebarriarteun-Aranzabal, C Quinones, E Martinez, T Vega, A Garcia, J Gimenez, J M Vanrell, D Castrillejo, A Larrauri.
Abstract
Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: -9 to 62), 33% (95% CI: -33 to 67) and 28% (95% CI: -33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: -11 to 72), 36% (95% CI: -64 to 75) and 42% (95% CI: -29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.Entities:
Mesh：
Substances：
Year: 2014 PMID： 24626206 DOI： 10.2807/1560-7917.es2014.19.9.20727
Source DB: PubMed Journal: Euro Surveill ISSN： 1025-496X